{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:36Z","timestamp":1786985076395,"version":"build-2736575974"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bcp.2020.114107","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T01:32:47Z","timestamp":1592703167000},"page":"114107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases"],"prefix":"10.1016","volume":"181","author":[{"given":"Fernanda C","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114107_b0005","doi-asserted-by":"crossref","unstructured":"Van der Schyf CJ, Youdim MB. Multifunctional drugs as neurotherapeutics. Neurotherapeutics. 2009;6:1-3.","DOI":"10.1016\/j.nurt.2008.11.001"},{"key":"10.1016\/j.bcp.2020.114107_b0010","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ps.3872","article-title":"Effect of insecticidal fusion proteins containing spider toxins targeting sodium and calcium ion channels on pyrethroid-resistant strains of peach-potato aphid (Myzus persicae)","volume":"71","author":"Yang","year":"2015","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.bcp.2020.114107_b0020","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0028-3908(99)00267-1","article-title":"Inhibition of neuronal high-voltage activated calcium channels by the \u03c9-Phoneutria nigriventer Tx3-3 peptide toxin","volume":"39","author":"Leao","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114107_b0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/mol.115.098178","article-title":"Identification and characterization of ProTx-III [\u03bc-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula Thrixopelma pruriens","volume":"88","author":"Cardoso","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0030","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1111\/bph.13865","article-title":"Modulatory features of the novel spider toxin \u03bc-TRTX-Df1a isolated from the venom of the spider Davus fasciatus","volume":"174","author":"Cardoso","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0035","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/1873-3468.13530","article-title":"Scorpion toxins interact with nicotinic acetylcholine receptors","volume":"593","author":"Kasheverov","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2020.114107_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20041379","article-title":"K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom","volume":"385","author":"Mouhat","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2020.114107_b0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.toxicon.2006.09.014","article-title":"ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels","volume":"49","author":"Priest","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-6606-7-36","article-title":"Block of T-type calcium channels by protoxins I and II","volume":"7","author":"Bladen","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bcp.2020.114107_b0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fevo.2019.00218","article-title":"Multifunctional toxins in snake venoms and therapeutic implications: From pain to hemorrhage and necrosis","volume":"7","author":"Ferraz","year":"2019","journal-title":"Front. Ecol. Evol."},{"key":"10.1016\/j.bcp.2020.114107_b0060","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/bph.13962","article-title":"Sodium channels and pain: from toxins to therapies","volume":"175","author":"Cardoso","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104532","article-title":"Modified age-dependent expression of NaV1.6 in an ALS model correlates with motor cortex excitability alterations","volume":"130","author":"Saba","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2020.114107_b0070","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/bph.13789","article-title":"Calcium channel modulation as a target in chronic pain control","volume":"175","author":"Patel","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0075","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.26210","article-title":"Overexpression of NaV1.6 channels is associated with the invasion capacity of human cervical cancer","volume":"130","author":"Hernandez-Plata","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2020.114107_b0080","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2020.114107_b0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1113\/JP273461","article-title":"Voltage-gated sodium channels: (NaV)igating the field to determine their contribution to visceral nociception","volume":"596","author":"Erickson","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2020.114107_b0090","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/nmo.12979","article-title":"Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome","volume":"28","author":"Fuentes","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bcp.2020.114107_b0095","article-title":"NaV1.1 inhibition can reduce visceral hypersensitivity","author":"Salvatierra","year":"20183","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2020.114107_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13460","article-title":"The influence of voltage-gated sodium channels on human gastrointestinal nociception","volume":"31","author":"Coates","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bcp.2020.114107_b0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.expneurol.2008.12.012","article-title":"Mexiletine-responsive erythromelalgia due to a new NaV1.7 mutation showing use-dependent current fall-off","volume":"216","author":"Choi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2020.114107_b0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/brain\/awy329","article-title":"Lacosamide in patients with NaV1.7 mutations-related small fibre neuropathy: a randomized controlled trial","volume":"142","author":"de Greef","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114107_b0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/01.wnl.0000268065.16865.5f","article-title":"Paroxysmal extreme pain disorder (previously familial rectal pain syndrome)","volume":"69","author":"Fertleman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2020.114107_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2474-13-23","article-title":"A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia","volume":"13","author":"Vargas-Alarcon","year":"2012","journal-title":"BMC Musculoskelet Disord."},{"key":"10.1016\/j.bcp.2020.114107_b0125","doi-asserted-by":"crossref","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function NaV1.8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2020.114107_b0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pain.2005.08.003","article-title":"Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs","volume":"118","author":"Garry","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2020.114107_b0135","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1038\/s41598-018-22216-w","article-title":"Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114107_b0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neuroscience.2015.02.010","article-title":"Local knockdown of the NaV1.6 sodium channel reduces pain behaviors, sensory neuron excitability, and sympathetic sprouting in rat models of neuropathic pain","volume":"291","author":"Xie","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2020.114107_b0145","doi-asserted-by":"crossref","first-page":"29341","DOI":"10.1074\/jbc.M404167200","article-title":"Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat","volume":"279","author":"Hong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.290.5489.124","article-title":"Potent analgesic effects of GDNF in neuropathic pain states","volume":"290","author":"Boucher","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114107_b0155","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/bja\/ael096","article-title":"Antinociceptive effects of tetrodotoxin (TTX) in rodents","volume":"96","author":"Marcil","year":"2006","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bcp.2020.114107_b0160","first-page":"11","article-title":"Antihyperalgesic effects of ProTx-II, a NaV1.7 antagonist, and A803467, a NaV1.8 antagonist, in diabetic mice","volume":"7","author":"Tanaka","year":"2015","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0165","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3390\/toxins6082363","article-title":"Synthesis and analgesic effects of \u03bc-TRTX-Hhn1b on models of inflammatory and neuropathic pain","volume":"6","author":"Liu","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2020.114107_b0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/09298665113206660119","article-title":"Analgesic effects of Huwentoxin-IV on animal models of inflammatory and neuropathic pain","volume":"21","author":"Liu","year":"2014","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bcp.2020.114107_b0175","doi-asserted-by":"crossref","unstructured":"Meng P, Huang H, Wang G, Yang S, Lu Q, Liu J, et al. A novel toxin from Haplopelma lividum selectively inhibits the NaV1.8 channel and possesses potent analgesic efficacy. Toxins. 2016;9.","DOI":"10.3390\/toxins9010007"},{"key":"10.1016\/j.bcp.2020.114107_b0180","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1073\/pnas.0601819103","article-title":"\u03bcO-conotoxin MrVIB selectively blocks NaV1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits","volume":"103","author":"Ekberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.SA."},{"key":"10.1016\/j.bcp.2020.114107_b0185","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1021\/bi060159+","article-title":"Synthetic \u03bcO-conotoxin MrVIB blocks TTX-resistant sodium channel NaV1.8 and has a long-lasting analgesic activity","volume":"45","author":"Bulaj","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2020.114107_b0190","doi-asserted-by":"crossref","unstructured":"Feng XJ, Ma LX, Jiao C, Kuang HX, Zeng F, Zhou XY, et al. Nerve injury elevates functional CaV3.2 channels in superficial spinal dorsal horn. Mol Pain. 2019;15:1744806919836569.","DOI":"10.1177\/1744806919836569"},{"key":"10.1016\/j.bcp.2020.114107_b0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnmol.2018.00024","article-title":"Accumulation of CaV3.2 T-type calcium channels in the uninjured sural nerve contributes to neuropathic pain in rats with spared nerve injury","volume":"11","author":"Chen","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2020.114107_b0200","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/pm\/pny132","article-title":"Intrathecal therapy for chronic pain: a review of morphine and ziconotide as firstline options","volume":"20","author":"Deer","year":"2019","journal-title":"Pain Med."},{"key":"10.1016\/j.bcp.2020.114107_b0205","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/mol.111.073205","article-title":"TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent","volume":"80","author":"Choe","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0210","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.12688\/f1000research.16104.1","article-title":"Voltage-gated calcium channel \u03b12\u03b4 subunits: an assessment of proposed novel roles","volume":"7","author":"Dolphin","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.bcp.2020.114107_b0215","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2020.114107_b0220","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fnins.2018.00931","article-title":"Mechanisms underlying overactive bladder and interstitial cystitis\/painful bladder syndrome","volume":"12","author":"Grundy","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2020.114107_b0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-physiol-020518-114525","article-title":"Visceral pain","volume":"81","author":"Grundy","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bcp.2020.114107_b0230","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121000","article-title":"NaV1.1 inhibition can reduce visceral hypersensitivity","volume":"3","author":"Salvatierra","year":"2018","journal-title":"JCI Insight."},{"key":"10.1016\/j.bcp.2020.114107_b0235","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/nmo.12860","article-title":"Colonic overexpression of the T-type calcium channel CaV3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients","volume":"28","author":"Scanzi","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.bcp.2020.114107_b0240","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1073\/pnas.1100869108","article-title":"T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome","volume":"108","author":"Marger","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2020.114107_b0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2008.12.051","article-title":"The voltage-gated sodium channel NaV1.9 is required for inflammation-based urinary bladder dysfunction","volume":"452","author":"Ritter","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2020.114107_b0250","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1523\/JNEUROSCI.21-21-08690.2001","article-title":"The involvement of the tetrodotoxin-resistant sodium channel NaV1.8 (PN3\/SNS) in a rat model of visceral pain","volume":"21","author":"Yoshimura","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114107_b0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2018.01.037","article-title":"Involvement of the cystathionine-gamma-lyase\/CaV3.2 pathway in substance P-induced bladder pain in the mouse, a model for nonulcerative bladder pain syndrome","volume":"133","author":"Tsubota","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114107_b0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biocel.2018.02.017","article-title":"Contribution of membrane receptor signalling to chronic visceral pain","volume":"98","author":"Sadeghi","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2020.114107_b0265","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature17976","article-title":"Selective spider toxins reveal a role for the NaV1.1 channel in mechanical pain","volume":"534","author":"Osteen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114107_b0270","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/bph.14608","article-title":"Inhibition of CaV3.2 calcium channels: a new target for colonic hypersensitivity associated with low-grade inflammation","volume":"176","author":"Picard","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0275","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1152\/jn.00717.2014","article-title":"Experimental and computational evidence for an essential role of NaV1.6 in spike initiation at stretch-sensitive colorectal afferent endings","volume":"113","author":"Feng","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2020.114107_b0280","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ejpain.2007.12.011","article-title":"Lack of colonic-inflammation-induced acute visceral hypersensitivity to colorectal distension in NaV1.9 knockout mice","volume":"12","author":"Martinez","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.bcp.2020.114107_b0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpain.2005.02.009","article-title":"Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome","volume":"6","author":"Verne","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.bcp.2020.114107_b0290","first-page":"629","article-title":"Review of intravesical therapies for bladder pain syndrome\/interstitial cystitis","volume":"4","author":"Cvach","year":"2015","journal-title":"Transl. Androl. Urol."},{"issue":"12","key":"10.1016\/j.bcp.2020.114107_b0295","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","article-title":"Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Logroscino","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bcp.2020.114107_b0300","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.15585\/mmwr.mm6746a1","article-title":"Prevalence of amyotrophic lateral sclerosis - United States, 2015","volume":"67","author":"Mehta","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.bcp.2020.114107_b0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature","volume":"41","author":"Chio","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.bcp.2020.114107_b0310","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/19336950.2017.1380758","article-title":"Distribution and function of voltage-gated sodium channels in the nervous system","volume":"11","author":"Wang","year":"2017","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.bcp.2020.114107_b0315","article-title":"Ion channel dysfunction and altered motoneuron excitability in ALS","volume":"2","author":"LoRusso","year":"2019","journal-title":"Neurol. Disord. Epilepsy J."},{"key":"10.1016\/j.bcp.2020.114107_b0320","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10867-016-9411-x","article-title":"Mutant SOD1 protein increases NaV1.3 channel excitability","volume":"42","author":"Kubat Oktem","year":"2016","journal-title":"J. Biol. Phys."},{"key":"10.1016\/j.bcp.2020.114107_b0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13041-020-00577-6","article-title":"A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of CaV3.2 T-type channel activity","volume":"13","author":"Stringer","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bcp.2020.114107_b0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","article-title":"A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?","volume":"17","author":"Bellingham","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bcp.2020.114107_b0335","first-page":"CD001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2012","journal-title":"Cochr. Database Syst. Rev."},{"key":"10.1016\/j.bcp.2020.114107_b0340","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/epi.13692","article-title":"Adult motor phenotype differentiates dravet syndrome from Lennox-gastaut syndrome and links SCN1A to early onset parkinsonian features","volume":"58","author":"Aljaafari","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114107_b0345","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00415-015-7984-0","article-title":"Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia","volume":"263","author":"Schwarz","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.bcp.2020.114107_b0350","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.25188","article-title":"Mutations in SCN3A cause early infantile epileptic encephalopathy","volume":"83","author":"Zaman","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114107_b0355","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eplepsyres.2015.06.007","article-title":"Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy","volume":"115","author":"Berghuis","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bcp.2020.114107_b0360","unstructured":"Catterall WA. Sodium channel mutations and epilepsy. In: th, Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies. Bethesda (MD)2012."},{"key":"10.1016\/j.bcp.2020.114107_b0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jmg.2008.062323","article-title":"Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients","volume":"46","author":"Depienne","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcp.2020.114107_b0370","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1523\/JNEUROSCI.2475-09.2009","article-title":"A functional null mutation of SCN1B in a patient with Dravet syndrome","volume":"29","author":"Patino","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114107_b0375","doi-asserted-by":"crossref","first-page":"E8077","DOI":"10.1073\/pnas.1804764115","article-title":"Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death","volume":"115","author":"Richards","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2020.114107_b0380","doi-asserted-by":"crossref","unstructured":"Weuring WJ, Singh S, Volkers L, Rook MB, van 't Slot RH, Bosma M, et al. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome. PLoS One. 2020;15:e0219106.","DOI":"10.1371\/journal.pone.0219106"},{"key":"10.1016\/j.bcp.2020.114107_b0385","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1528-1167.2006.00482.x","article-title":"Functional analysis of Ca3.2 T-type calcium channel mutations linked to childhood absence epilepsy","volume":"47","author":"Peloquin","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2020.114107_b0390","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/hmg\/6.11.1973","article-title":"Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p","volume":"6","author":"Jodice","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2020.114107_b0395","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00424-010-0802-8","article-title":"CaV2.1 channelopathies","volume":"460","author":"Pietrobon","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2020.114107_b0400","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ajhg.2019.03.005","article-title":"Bi-allelic loss-of-function CACNA1B mutations in progressive epilepsy-dyskinesia","volume":"104","author":"Gorman","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcp.2020.114107_b0405","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2020.114107_b0410","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/tpj.2013.21","article-title":"Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II\/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy","volume":"14","author":"Benhaim","year":"2014","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.bcp.2020.114107_b0415","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1158\/0008-5472.CAN-10-1169","article-title":"Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion","volume":"70","author":"House","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2020.114107_b0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40880-017-0253-0","article-title":"Expression of voltage-gated sodium channel NaV1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-\u03b2 expression and clinical outcomes","volume":"36","author":"Peng","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.bcp.2020.114107_b0425","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/ijc.30381","article-title":"Voltage-gated sodium channel NaV1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1","volume":"139","author":"Xia","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2020.114107_b0430","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-05-0327","article-title":"Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis","volume":"11","author":"Fraser","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2020.114107_b0435","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/pros.1095","article-title":"Expression profiles of voltage-gated Na+ channel \u03b1-subunit genes in rat and human prostate cancer cell lines","volume":"48","author":"Diss","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2020.114107_b0440","first-page":"4939","article-title":"Functional expression of the voltage-gated Na+-channel NaV1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells","volume":"126","author":"Campbell","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2020.114107_b0445","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1002\/jcp.27399","article-title":"Colorectal cancer invasiveness in vitro: Predominant contribution of neonatal NaV1.5 under normoxia and hypoxia","volume":"234","author":"Guzel","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2020.114107_b0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0065-2660(08)01001-8","article-title":"Periodic paralysis","volume":"63","author":"Fontaine","year":"2008","journal-title":"Adv. Genet."},{"key":"10.1016\/j.bcp.2020.114107_b0455","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mus.26009","article-title":"Review of the diagnosis and treatment of periodic paralysis","volume":"57","author":"Statland","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bcp.2020.114107_b0460","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1085\/jgp.201711923","article-title":"An atypical CaV1.1 mutation reveals a common mechanism for hypokalemic periodic paralysis","volume":"149","author":"Cannon","year":"2017","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bcp.2020.114107_b0465","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/brain\/awu015","article-title":"NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery","volume":"137","author":"Groome","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2020.114107_b0470","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1440-1789.2008.00985.x","article-title":"Tubular aggregates in paralysis periodica paramyotonica with T704M mutation of SCN4A","volume":"29","author":"Luan","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/j.bcp.2020.114107_b0475","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3988\/jcn.2009.5.4.186","article-title":"Clinical diversity of SCN4A-mutation-associated skeletal muscle sodium channelopathy","volume":"5","author":"Lee","year":"2009","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.bcp.2020.114107_b0480","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ana.410330312","article-title":"Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis","volume":"33","author":"Ptacek","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2020.114107_b0485","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10571-007-9231-4","article-title":"Hongbin W, Yiling S, MaoYanling. Mutations of sodium channel \u03b1-subunit genes in Chinese patients with normokalemic periodic paralysis","volume":"28","author":"Xiuhai","year":"2008","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2020.114107_b0490","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.toxicon.2018.07.008","article-title":"Phoneutria nigriventer venom: A pharmacological treasure","volume":"151","author":"Peigneur","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0495","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0041-0101(03)00011-4","article-title":"Molecular cloning and characterization of Phoneutria nigriventer toxins active on calcium channels","volume":"41","author":"Cardoso","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0500","doi-asserted-by":"crossref","first-page":"40883","DOI":"10.1038\/srep40883","article-title":"Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a","volume":"7","author":"Deuis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114107_b0505","doi-asserted-by":"crossref","first-page":"22707","DOI":"10.1074\/jbc.M113.461392","article-title":"Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (\u03bc-TRTX-Hh2a)","volume":"288","author":"Minassian","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0510","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2018.02.016","article-title":"Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches","volume":"133","author":"Goncalves","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114107_b0515","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.105.087023","article-title":"Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6","volume":"314","author":"Vieira","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2020.114107_b0520","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1021\/bi026546a","article-title":"Two tarantula peptides inhibit activation of multiple sodium channels","volume":"41","author":"Middleton","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2020.114107_b0525","doi-asserted-by":"crossref","first-page":"23894","DOI":"10.1038\/srep23894","article-title":"Molecular interactions between tarantula toxins and low-voltage-activated calcium channels","volume":"6","author":"Salari","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114107_b0530","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/mol.107.041046","article-title":"Inhibition of sodium channel gating by trapping the domain II voltage sensor with protoxin II","volume":"73","author":"Sokolov","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0535","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1254\/jphs.09356FP","article-title":"Tarantula toxin ProTx-I differentiates between human T-type voltage-gated Ca2+ Channels CaV3.1 and CaV3.2","volume":"112","author":"Ohkubo","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2020.114107_b0540","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.toxicon.2012.04.337","article-title":"Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads","volume":"60","author":"Klint","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0545","unstructured":"Cardoso FC, Castro J, Grundy L, Schober G, Zhao T, Herzig V, et al. Harnessing multifunctional spider-venom peptides to modulate pain pathways. 20th World Congress of the International Society of Toxinology. 2019; 8-13 September, Buenos Aires, Argentina."},{"key":"10.1016\/j.bcp.2020.114107_b0550","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/bph.14628","article-title":"From identification to functional characterization of cyriotoxin-1a, an antinociceptive toxin from the spider Cyriopagopus schioedtei","volume":"176","author":"Goncalves","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0555","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11090484","article-title":"Evaluation of the spider (Phlogiellus genus) Phlotoxin 1 and synthetic variants as antinociceptive drug candidates","volume":"11","author":"Goncalves","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.bcp.2020.114107_b0560","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1074\/jbc.M109.054718","article-title":"Target promiscuity and heterogeneous effects of tarantula venom peptides affecting Na+ and K+ ion channels","volume":"285","author":"Redaelli","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0565","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.peptides.2014.09.005","article-title":"Mapping the interaction site for the tarantula toxin hainantoxin-IV (\u03b2-TRTX-Hn2a) in the voltage sensor module of domain II of voltage-gated sodium channels","volume":"68","author":"Cai","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2020.114107_b0570","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxicon.2013.10.029","article-title":"Two tarantula venom peptides as potent and differential NaV channels blockers","volume":"77","author":"Cherki","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0575","doi-asserted-by":"crossref","first-page":"27300","DOI":"10.1074\/jbc.M708447200","article-title":"Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration","volume":"283","author":"Xiao","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0580","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fphar.2019.00366","article-title":"Structure-function and therapeutic potential of spider venom-derived cysteine knot peptides targeting sodium channels","volume":"10","author":"Cardoso","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.toxicon.2013.05.015","article-title":"Synthesis and biological characterization of synthetic analogs of Huwentoxin-IV (\u03bc-theraphotoxin-Hh2a), a neuronal tetrodotoxin-sensitive sodium channel inhibitor","volume":"71","author":"Deng","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0590","first-page":"835","article-title":"Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7","author":"Agwa","year":"1859","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"key":"10.1016\/j.bcp.2020.114107_b0595","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bcp.2014.02.008","article-title":"Isolation, synthesis and characterization of \u03c9-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type CaV channels","volume":"89","author":"Klint","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0600","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bph.13652","article-title":"The peptide Ph\u03b11\u03b2, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice","volume":"174","author":"Tonello","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0605","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1074\/jbc.M112348200","article-title":"Phoneutria nigriventer \u03c9-phonetoxin IIA blocks the CaV2 family of calcium channels and interacts with \u03c9-conotoxin-binding sites","volume":"277","author":"Dos Santos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0610","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-3495(01)75681-0","article-title":"Interaction of SNX482 with domains III and IV inhibits activation gating of \u03b11E CaV2.3 calcium channels","volume":"81","author":"Bourinet","year":"2001","journal-title":"Biophys. J ."},{"key":"10.1016\/j.bcp.2020.114107_b0615","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.20-01-00171.2000","article-title":"Alpha1E subunits form the pore of three cerebellar R-type calcium channels with different pharmacological and permeation properties","volume":"20","author":"Tottene","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114107_b0620","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0041-0101(00)00150-1","article-title":"The effect of Huwentoxin-I on Ca2+ channels in differentiated NG108-15 cells, a patch-clamp study","volume":"39","author":"Peng","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0625","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bbrc.2007.02.168","article-title":"The cross channel activities of spider neurotoxin huwentoxin-I on rat dorsal root ganglion neurons","volume":"357","author":"Wang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2020.114107_b0630","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1124\/mol.52.6.1095","article-title":"Voltage-dependent inhibition of N- and P-type calcium channels by the peptide toxin \u03c9-grammotoxin-SIA","volume":"52","author":"McDonough","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0635","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0026-895X(25)10037-0","article-title":"Omega-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons","volume":"48","author":"Piser","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0640","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41594-018-0033-9","article-title":"Screening, large-scale production and structure-based classification of cystine-dense peptides","volume":"25","author":"Correnti","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2020.114107_b0645","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1073\/pnas.95.15.8585","article-title":"Gating modifier toxins reveal a conserved structural motif in voltage-gated Ca2+ and K+ channels","volume":"95","author":"Li-Smerin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2020.114107_b0650","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-2836(02)00595-8","article-title":"Solution structure of \u03c9-grammotoxin SIA, a gating modifier of P\/Q and N-type Ca2+ channel","volume":"321","author":"Takeuchi","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bcp.2020.114107_b0655","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.aaw2493","article-title":"Structures of human NaV1.7 channel in complex with auxiliary subunits and animal toxins","volume":"363","author":"Shen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114107_b0660","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1021\/jm501400p","article-title":"Understanding the molecular basis of toxin promiscuity: the analgesic sea anemone peptide APETx2 interacts with acid-sensing ion channel 3 and hERG channels via overlapping pharmacophores","volume":"57","author":"Jensen","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0665","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/mol.108.047670","article-title":"ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors","volume":"74","author":"Schmalhofer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0670","doi-asserted-by":"crossref","first-page":"39662","DOI":"10.1038\/srep39662","article-title":"Insensitivity to pain induced by a potent selective closed-state NaV1.7 inhibitor","volume":"7","author":"Flinspach","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114107_b0675","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature07473","article-title":"Deconstructing voltage sensor function and pharmacology in sodium channels","volume":"456","author":"Bosmans","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114107_b0680","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/mol.110.066332","article-title":"The tarantula toxins ProTx-II and huwentoxin-IV differentially interact with human NaV1.7 voltage sensors to inhibit channel activation and inactivation","volume":"78","author":"Xiao","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0685","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/bph.13081","article-title":"Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach","volume":"172","author":"Klint","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0690","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/jm501765v","article-title":"Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the NaV1.7 sodium channel","volume":"58","author":"Murray","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0695","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.toxicon.2011.06.006","article-title":"Characterization of voltage-dependent calcium channel blocking peptides from the venom of the tarantula Grammostola rosea","volume":"58","author":"Ono","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0700","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1021\/acs.jmedchem.5b01947","article-title":"Single residue substitutions that confer voltage-gated sodium ion channel subtype selectivity in the NaV1.7 inhibitory peptide GpTx-1","volume":"59","author":"Murray","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0705","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1021\/jm500687u","article-title":"Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channels","volume":"57","author":"Park","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114107_b0710","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2019-0070","article-title":"Analgesic and side effects of intravenous recombinant Ph\u03b11\u03b2","volume":"26","author":"Rigo","year":"2020","journal-title":"J. Venom Anim Toxins Incl. Trop Dis."},{"key":"10.1016\/j.bcp.2020.114107_b0715","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.toxicon.2011.09.008","article-title":"Antiallodynic effect and side effects of Ph\u03b11\u03b2, a neurotoxin from the spider Phoneutria nigriventer: comparison with \u03c9-conotoxin MVIIA and morphine","volume":"58","author":"de Souza","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2020.114107_b0720","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/cas.12209","article-title":"Spider peptide Ph\u03b11\u03b2 induces analgesic effect in a model of cancer pain","volume":"104","author":"Rigo","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2020.114107_b0725","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/j.pain.0000000000001567","article-title":"Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen","volume":"160","author":"Mueller","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2020.114107_b0730","unstructured":"Bloch MJ, Basile J. Major side effects and safety of calcium channel blockers. UpToDate. Accessed 10 June 2020."},{"key":"10.1016\/j.bcp.2020.114107_b0735","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coph.2007.09.007","article-title":"Sodium channels and nociception: recent concepts and therapeutic opportunities","volume":"8","author":"Krafte","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114107_b0740","doi-asserted-by":"crossref","unstructured":"McDowell GC, Saulino MF, Wallace M, Grigsby EJ, Rauck RL, Kim P, et al. Effectiveness and safety of intrathecal Ziconotide: Final results of the patient registry of intrathecal Ziconotide management (PRIZM). Pain Med. 2020;pnaa115.","DOI":"10.1093\/pm\/pnaa115"},{"key":"10.1016\/j.bcp.2020.114107_b0745","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/bi00382a004","article-title":"Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using \u03c9-conotoxin from Conus magus venom","volume":"26","author":"Olivera","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2020.114107_b0750","doi-asserted-by":"crossref","first-page":"10256","DOI":"10.1021\/bi00032a020","article-title":"Three-dimensional structure in solution of the calcium channel blocker \u03c9-conotoxin MVIIA","volume":"34","author":"Kohno","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2020.114107_b0755","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2015.08.047","article-title":"Molecular basis of toxicity of N-type calcium channel inhibitor MVIIA","volume":"101","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114107_b0760","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-019-1801-3","article-title":"Cryo-EM structures of apo and antagonist-bound human CaV3.1","volume":"576","author":"Zhao","year":"2019","journal-title":"Nature"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:17:14Z","timestamp":1757769434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":152,"alternative-id":["S0006295220303439"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114107","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114107"}}